West Pharmaceutical Servs Analyst Ratings and Price Targets | NYSE:WST

Comments

West Pharmaceutical Servs Analyst Ratings

WSTNYSE

Logo brought to you by Benzinga Data

Trade with Public

$247.78

-7.38-2.89%

At close: Jan 22, 4:00 PM EST

$248.10

0.320.13%

After Hours: 5:48 PM EST

The dividend Ex-Date is in 6 days

Overview News Earnings Options Guidance Dividends

Analyst Ratings

Insider Trades Short Interest Government Trades Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$536.00

Lowest Price Target¹

$285.00

Consensus Price Target¹

$367.91

West Pharmaceutical Servs Analyst Ratings and Price Targets | NYSE:WST | Benzinga

West Pharmaceutical Services Inc has a consensus price target of $367.91 based on the ratings of 12 analysts. The high is $536 issued by Jefferies on February 7, 2024. The low is $285 issued by Morgan Stanley on December 2, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, TD Cowen, and Barclays on December 2, 2025, October 29, 2025, and October 27, 2025, respectively. With an average price target of $320 between Morgan Stanley, TD Cowen, and Barclays, there's an implied 28.98% upside for West Pharmaceutical Services Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Jul 25

Sep 25

Oct 25

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Morgan Stanley

TD Cowen

Barclays

UBS

Keybanc

¹calculated from analyst ratings

Analyst Ratings for West Pharmaceutical Servs

	Buy Now						Get Alert
12/02/2025	Buy Now	14.87%	Morgan Stanley	→ $285	Initiates	→ Equal-Weight	Get Alert
10/29/2025	Buy Now	41.07%	TD Cowen	→ $350	Initiates	→ Buy	Get Alert
10/27/2025	Buy Now	31%	Barclays	$275 → $325	Maintains	Equal-Weight	Get Alert
10/24/2025	Buy Now	43.09%	UBS	$320 → $355	Maintains	Buy	Get Alert
10/24/2025	Buy Now	41.07%	Keybanc	$325 → $350	Maintains	Overweight	Get Alert
10/23/2025	Buy Now	57.19%	Evercore ISI Group	$350 → $390	Maintains	Outperform	Get Alert
10/02/2025	Buy Now	10.84%	Barclays	$260 → $275	Maintains	Equal-Weight	Get Alert
09/15/2025	Buy Now	25.35%	Rothschild & Co	→ $311	Initiates	→ Buy	Get Alert
07/25/2025	Buy Now	4.8%	Barclays	$245 → $260	Maintains	Equal-Weight	Get Alert
07/25/2025	Buy Now	28.98%	UBS	$285 → $320	Maintains	Buy	Get Alert
07/25/2025	Buy Now	41.07%	Evercore ISI Group	$275 → $350	Maintains	Outperform	Get Alert
06/24/2025	Buy Now	-1.25%	Barclays	→ $245	Initiates	→ Equal-Weight	Get Alert
03/18/2025	Buy Now	10.84%	Evercore ISI Group	→ $275	Initiates	→ Outperform	Get Alert
02/14/2025	Buy Now	31%	Keybanc	$470 → $325	Maintains	Overweight	Get Alert
01/08/2025	Buy Now	61.23%	Citigroup	→ $400	Initiates	→ Buy	Get Alert
12/13/2024	Buy Now	43.09%	B of A Securities	$350 → $355	Maintains	Buy	Get Alert
12/13/2024	Buy Now	—	Wolfe Research	—	Initiates	→ Peer Perform	Get Alert
12/12/2024	Buy Now	57.19%	UBS	$350 → $390	Upgrade	Neutral → Buy	Get Alert
02/16/2024	Buy Now	51.15%	UBS	$400 → $375	Maintains	Neutral	Get Alert
02/13/2024	Buy Now	89.44%	Keybanc	$440 → $470	Maintains	Overweight	Get Alert
02/07/2024	Buy Now	116.04%	Jefferies	$323 → $536	Upgrade	Hold → Buy	Get Alert
10/27/2023	Buy Now	57.19%	Stephens & Co.	$420 → $390	Maintains	Overweight	Get Alert
08/30/2023	Buy Now	77.35%	Keybanc	$415 → $440	Maintains	Overweight	Get Alert
08/21/2023	Buy Now	67.27%	Keybanc	$385 → $415	Maintains	Overweight	Get Alert
07/28/2023	Buy Now	55.18%	Keybanc	$375 → $385	Maintains	Overweight	Get Alert
07/17/2023	Buy Now	69.29%	Stephens & Co.	$400 → $420	Maintains	Overweight	Get Alert
06/16/2023	Buy Now	63.24%	B of A Securities	$390 → $405	Upgrade	Neutral → Buy	Get Alert
04/11/2023	Buy Now	61.23%	Stephens & Co.	$330 → $400	Upgrade	Equal-Weight → Overweight	Get Alert
02/17/2023	Buy Now	51.15%	Keybanc	$315 → $375	Maintains	Overweight	Get Alert

FAQ

What is the target price for West Pharmaceutical Servs (WST) stock?

The latest price target for West Pharmaceutical Servs (NYSE:WST) was reported by Morgan Stanley on December 2, 2025. The analyst firm set a price target for $285.00 expecting WST to rise to within 12 months (a possible 14.87% upside). 14 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for West Pharmaceutical Servs (WST)?

The latest analyst rating for West Pharmaceutical Servs (NYSE:WST) was provided by Morgan Stanley, and West Pharmaceutical Servs initiated their equal-weight rating.

When was the last upgrade for West Pharmaceutical Servs (WST)?

The last upgrade for West Pharmaceutical Services Inc happened on December 12, 2024 when UBS raised their price target to $390. UBS previously had a neutral for West Pharmaceutical Services Inc.

When was the last downgrade for West Pharmaceutical Servs (WST)?

There is no last downgrade for West Pharmaceutical Servs.

When is the next analyst rating going to be posted or updated for West Pharmaceutical Servs (WST)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of West Pharmaceutical Servs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for West Pharmaceutical Servs was filed on December 2, 2025 so you should expect the next rating to be made available sometime around December 2, 2026.

Is the Analyst Rating West Pharmaceutical Servs (WST) correct?

While ratings are subjective and will change, the latest West Pharmaceutical Servs (WST) rating was a initiated with a price target of $0.00 to $285.00. The current price West Pharmaceutical Servs (WST) is trading at is $248.10, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.